Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
0 hedge funds and large institutions have $0 invested in Immune Design Corp. in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 66 closing their positions.
100% less funds holding
Funds holding: 68 → 0 (-68)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $165M → $0 (-$165M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 66
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PS
Peter Svennilson
|
-$38.9M |
| 2 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$14M |
| 3 |
BlackRock
New York
|
-$13.1M |
| 4 |
TAL
TIG Advisors LLC
New York
|
-$11.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.9M |
IMDZ Hedge Fund Activity: Q2 2019 in Review
0 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q2 2019, worth a combined $0 — down 100% from $165M a quarter earlier.
Sellers outnumbered buyers: 66 funds closed out of IMDZ and 0 opened new positions — a net loss of 66 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Peter Svennilson, exiting entirely with an estimated $38.9M sold.
- 0 institutional investors held Immune Design Corp. (IMDZ) as of Q2 2019, down from 68 in Q1 2019.
- Funds reported $0 of Immune Design Corp. stock for Q2 2019, down 100% quarter-over-quarter.
- 0 funds opened new Immune Design Corp. positions in Q2 2019 and 66 closed out, a net change of -66 holders.
- The largest Immune Design Corp. seller in Q2 2019 was Peter Svennilson, an estimated $38.9M sold.
Based on aggregated 13F filings for Q2 2019.